DIRS.INFO The most relevant business & tech news

☆ Novavax to settle dispute over canceled Covid vaccine purchase agreement
▼ + stars: | 2024-02-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Novavax on Thursday said it will settle a bitter arbitration dispute with Gavi, a nongovernmental global vaccine organization, over a canceled Covid vaccine purchase agreement. In 2022, Novavax terminated a purchase agreement with Geneva-based Gavi. Under the settlement, Novavax has paid an initial $75 million to Gavi and will make deferred payments of $80 million each year through Dec. 31. Analysts had previously told CNBC that Novavax could "be in trouble" if the arbitration forced it to pay the full $700 million to Gavi in 2023.

Persons: Novavax, Gavi, bode, David Marlow Organizations: Dutch Health Service Organization, CNBC Locations: The Hague, Netherlands, Geneva, Novavax

Cameroon will be the first country to routinely give children a new malaria vaccine as the shots are rolled out in Africa. Gavi said it is working with 20 other African countries to help them get the vaccine and that those countries will hopefully immunize more than 6 million children through 2025. Political Cartoons View All 253 ImagesCameroon will use the first of two recently approved malaria vaccines, known as Mosquirix. That vaccine is cheaper, requires three doses and India’s Serum Institute said they could make up to 200 million doses a year. Neither of the malaria vaccines stop transmission, so other tools like bed nets and insecticidal spraying will still be critical.

Persons: Aurelia Nguyen, Gavi, Gavi's Nguyen Organizations: World Health Organization, GlaxoSmithKline, GSK, Oxford University, WHO, Serum Institute, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: Cameroon, Africa, Central Africa, Oxford

☆ Cameroon Launches Malaria Vaccination Programme in Global Milestone
▼ + stars: | 2024-01-22 | by ( Jan. | At A.M. | ) www.usnews.com time to read: +2 min

(Reuters) - The global fight against malaria took a stride forward on Monday as Cameroon launched the world's first routine vaccine programme against the mosquito-borne disease that is projected to save tens of thousands of children's lives per year across Africa. After successful trials, including in Ghana and Kenya, Cameroon is the first country to administer doses through a routine immunisation programme that 19 other countries aim to roll out this year, according to global vaccine alliance Gavi. Around 6.6 million children in these countries are targeted for malaria vaccination through 2024-25. Rolling out the second vaccine "is expected to result in sufficient vaccine supply to meet the high demand and reach millions more children," the WHO's director of immunization, Kate O'Brien, said at the briefing. This R21 vaccine, developed by University of Oxford, could be launched in May or June, said Gavi's Chief Programme Officer Aurelia Nguyen.

Persons: Mohammed Abdulaziz of, Kate O'Brien, Aurelia Nguyen, Alessandra Prentice, Jennifer Rigby, Hugh Lawson Organizations: Reuters, World Health Organization, WHO, British, GSK, for Disease Control, Prevention, University of Oxford Locations: Cameroon, Africa, Ghana, Kenya

☆ Gavi strike sends Spain to Euro 2024, Turkey and Scotland also qualify
▼ + stars: | 2023-10-15 | by ( Philip O'Connor | ) www.reuters.com time to read: +3 min

The Spain striker was the centre of attention again when midfielder Gavi fired home four minutes after the break and another VAR offside check ensued, but this time he was in the clear and the goal was allowed to stand. Norway set up to hit Spain on the break but struggled to create much in attack as the visitors kept striker Erling Haaland shackled to reach the finals with two games to spare. A brilliant volley from Yunus Akgun just before the hour put Turkey on course for a comprehensive win against Latvia that ensured they will take their place at next year's tournament. The Turks top their group with 16 points, six points ahead of Wales and Croatia after the Welsh beat the Croats 2-1 in Cardiff to keep their qualifying hopes alive. Reporting by Philip O'Connor, Tommy Lund and Anita Kobylinska; Editing by Ken FerrisOur Standards: The Thomson Reuters Trust Principles.

Persons: Gavi's, Alvaro Morata, Gavi, Erling Haaland, Yunus Akgun, Cenk, Poland's, Robert Lewandowski, Ion Nicolaescu, Karol Swiderski, Philip O'Connor, Tommy Lund, Anita Kobylinska, Ken Ferris Organizations: Norway, Group, Scotland, Latvia, Turks, Welsh, Israel, Thomson Locations: Spain, Norway, Germany Turkey, Latvia, Turkey, Oslo, Kerem, Germany, Wales, Croatia, Cardiff, Switzerland, Belarus, Romania, Andorra, Swiss, Pristina, Moldova, Albania, Czech Republic

Gavi's winning goal for Spain against Norway in a European Championship qualifier on Sunday will likely have been cheered as wildly in Glasgow as it was in Madrid. The Barcelona midfielder's strike at Ullevaal Stadium in Oslo secured a 1-0 win that means both Spain and Scotland have qualified for Euro 2024. Scotland might not harbor realistic ambitions of winning Euro 2024, but it has arguably exceeded expectations by qualifying from Group A. Wales moved up to second in the group ahead of Croatia in third, with both teams on 10 points. Poland drew 1-1 with Moldova to leave those teams three points and four points off the top respectively.

Persons: Gavi's, Luka, Josko Gvardiol, Marcelo Brozovic, Harry Wilson, Mario Pasalic, Yunus Akgun, Cenk Tosun, Kerem Akturkoglu, ___ James Robson Organizations: Spain, Sunday, Ullevaal, Scotland, Turkey, Latvia, European, Wales, ALBANIA, Faroe, Albania, Andorra — Locations: Norway, Glasgow, Madrid, Barcelona, Oslo, Spain, Scotland, Germany, Konya Metropolitan, Croatia, Wales, CROATIA, Qatar, Turkey, Albania, Poland, Moldova, Romania, Switzerland, Belarus, Georgia, Cyprus

☆ Lewandowski and Cancelo strike as Barca snatch 3-2 win over Celta
▼ + stars: | 2023-09-23 | by ( ) www.reuters.com time to read: +2 min

BARCELONA, Sept 23 (Reuters) - Robert Lewandowski scored a quickfire double before Joao Cancelo sealed a last-gasp 3-2 win for Barcelona over Celta Vigo in a LaLiga clash at the Estadi Olimpic Lluis Companys on Saturday. The win provisionally moves Barcelona to the top of the league standings with 16 points from six games, one point ahead of Real Madrid who face local rivals Atletico Madrid on Sunday. We played with faith, with courage, although we were a bit sloppy at times," Barcelona manager Xavi Hernandez said. Strand Larsen nearly doubled his tally just before half-time but the Norwegian's bullet header was thwarted by Ter Stegen. Cancelo then ghosted between two Celta defenders to get on the end of Gavi's inch-perfect cross to snatch victory from the jaws of defeat and seal a fifth straight league win for Barca.

Persons: Robert Lewandowski, Joao Cancelo, Lluis Companys, Xavi Hernandez, It's, Iago Aspas, Andre ter Stegen, Jorgen Strand Larsen, Ter, Luca de la Torre, Strand Larsen, Ter Stegen, Xavi, Lamine Yamal, Ronald Araujo, Tasos Douvikas, Lewandowski, Ivan Villar, Cancelo, Aadi Nair, Clare Fallon Organizations: Barcelona, Celta Vigo, Atletico Madrid, Sunday, Celta, Royal, Real Betis, Barca, Thomson Locations: BARCELONA, Barcelona, Real Madrid, Royal Antwerp, Ter Stegen's, Bengaluru

☆ Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
▼ + stars: | 2023-06-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +10 min

Jakub Porzycki | NurPhoto | Getty ImagesNovavax has a clear message for Wall Street: The cash-strapped Covid vaccine maker sees a pathway to survival. The 36-year-old company will continue to rely on its protein-based Covid vaccine – its only commercially available product – for most of its revenue this year. Once the U.S. government's supply of free Covid vaccines runs out, all three companies will sell updated shots directly to health-care providers. A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. But Taylor emphasized that the plan will help Novavax refocus on its top priority: delivering an updated vaccine in the coming months.

Persons: Jakub Porzycki, Novavax, Covid, Cowen, Brendan Smith, John Jacobs, Smith, that's, Silvia Taylor, Taylor, Jefferies, Roger Song, Patrick Van Katwijk, Mayank Mamtani, let's, Mamtani, Let's, Song, Ding Genhou Organizations: NurPhoto, Getty, Pfizer, Moderna, CNBC, Food and Drug Administration, World Health Organization, FDA, Dutch Health Service Organization, Riley Securities, U.S, Centers for Disease Control, CDC, Reuters, Visual China Locations: Krakow, Poland, Maryland, U.S, The Hague, Netherlands, Moderna, Geneva, Hohhot, Inner Mongolia Autonomous Region, China

Oxford scientist Adrian Hill said Ghana's drug regulator has approved the vaccine domestically for the age group at highest risk of death from malaria - children aged 5 months to 36 months. Oxford has a deal with Serum Institute of India to produce up to 200 million doses of the vaccine - known as R21 - annually. "This shows how close the world is to having a second approved vaccine to fight malaria," he said. MEETING THE NEEDThe first malaria vaccine, Mosquirix from British drugmaker GSK (GSK.L), was endorsed by the WHO last year after decades of work. Since it began in 2019, 1.2 million children across the three countries have received at least one dose of the Mosquirix vaccine.

☆ Gavi rejects Novavax's claim on COVID vaccine deal breach
▼ + stars: | 2022-11-22 | by ( ) www.reuters.com time to read: +2 min

Nov 22 (Reuters) - Global vaccine alliance Gavi on Tuesday rejected Novavax's (NVAX.O) claim that the group had breached an advance purchase agreement to procure 350 million doses of the company's COVID-19 vaccine. Novavax also has a pact with Serum Institute of India for manufacturing a version of the vaccine under the brand Covovax, which would also be supplied to the COVAX facility. Gavi's spokesperson said Serum Institute had a 300 million dose commitment for Covovax, with options for 750 million more doses if needed. A spokesperson for Serum Institute declined to comment. Novavax recently cut its full-year forecast yet again, hurt by late authorizations of its COVID vaccine globally amid a waning demand for shots.

☆ Novavax ends COVID vaccine sale agreement with Gavi
▼ + stars: | 2022-11-21 | by ( ) www.reuters.com time to read: +2 min

Nov 21 (Reuters) - Novavax Inc (NVAX.O) said on Monday it had delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of the company's COVID-19 vaccine to low- and middle-income countries. The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility. Novavax received a non-refundable advance payment of $350 million from Gavi last year and an additional $350 million this year after the vaccine got the WHO's emergency use listing, the company said. The company had earlier this month cut its full-year forecast yet again, hurt by late authorizations of its vaccine globally. Covovax and Serum's vaccines were the ninth and tenth vaccine, respectively, to get the WHO's emergency listing.

Search resuls for: "Gavi's"

10 mentions found